학술논문
Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study
Document Type
Article
Author
Source
In: International Journal of STD and AIDS . (International Journal of STD and AIDS, January 2024, 35(1):33-38)
Subject
Language
English
ISSN
17581052
09564624
09564624